Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT04240535
PHASE4

Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris

Sponsor: Amir Moradi MD, MBA

View on ClinicalTrials.gov

Summary

Single Center, Double Blind, Placebo- Controlled Study of 20 subjects with 10 active drug/10 placebo Standardized baseline/pre-treatments and follow-up images will be taken. Subjects will receive injection of either study drug or placebo to the Depressor Anguli Oris. Follow ups will occur at 2 weeks, 4 weeks, and 12 weeks.

Official title: A Single Center, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2020-01

Completion Date

2020-07

Last Updated

2020-01-27

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

OnabotulinumtoxinA 50 UNT [Botox Cosmetic]

Injections to the Depressor Anguli Oris

Locations (1)

Moradi MD

Vista, California, United States